Carmel Capital Partners’s Labcorp LH Stock Holding History

Carmel Capital Partners’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.02M	Sell	10,801 -692	-6%	-$182K	1%	22
2026 Q1	$3.07M	Buy	11,493 +2,845	+33%	+$770K	1.11%	25
2025 Q4	$2.17M	Buy	8,648 +2,627	+44%	+$698K	0.76%	49
2025 Q3	$1.73M	Sell	6,021 -1,519	-20%	-$407K	0.73%	33
2025 Q2	$1.98M	Buy	7,540 +759	+11%	+$185K	0.69%	41
2025 Q1	$1.58M	Buy	6,781 +176	+3%	+$42.7K	0.62%	37
2024 Q4	$1.51M	Buy	6,605 +547	+9%	+$125K	0.61%	36
2024 Q3	$1.35M	Sell	6,058 -129	-2%	-$28.4K	0.52%	38
2024 Q2	$1.26M	Buy	6,187 +1,035	+20%	+$211K	0.53%	38
2024 Q1	$1.13M	Buy	5,152 +70	+1%	+$15.4K	0.47%	42
2023 Q4	$1.16M	Buy	5,082 +37	+0.7%	+$7.77K	0.59%	34
2023 Q3	$1.01M	Sell	5,045 -1,429	-22%	-$301K	0.46%	45
2023 Q2	$1.34M	Buy	6,474 +646	+11%	+$125K	0.69%	32
2023 Q1	$1.15M	Buy	5,828 +236	+4%	+$48.6K	0.68%	28
2022 Q4	$1.13M	Sell	5,592 -218	-4%	-$42.6K	0.78%	23
2022 Q3	$1.02M	Sell	5,810 -821	-12%	-$168K	0.99%	22
2022 Q2	$1.33M	Buy	6,631 +499	+8%	+$106K	1.25%	11
2022 Q1	$1.39M	Buy	6,132 +94	+2%	+$22.1K	1.16%	16
2021 Q4	$1.63M	Buy	+6,038	New	+$1.49M	1.22%	13

Other funds holding LH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Carmel Capital Partners's LH Position: Q2 2026 in Review

Carmel Capital Partners reduced its Labcorp (LH) stake by 6% in Q2 2026, selling an estimated $182K and leaving 10,801 shares worth $3.02M. The position accounts for 1% of the portfolio, ranked #22.

Carmel Capital Partners first reported a position in LH in Q4 2021 and has held it in 19 quarters since. The position peaked at $3.07M in Q1 2026. 1,059 funds tracked by Wall St. Rank hold LH as of Q2 2026.

Carmel Capital Partners held 10,801 shares of Labcorp worth $3.02M as of Q2 2026.
Carmel Capital Partners sold 692 Labcorp shares in Q2 2026, an estimated $182K.
Labcorp made up 1% of Carmel Capital Partners's portfolio in Q2 2026, its #22 holding.
Carmel Capital Partners first reported a position in Labcorp in Q4 2021 and has held it in 19 quarters since.
Carmel Capital Partners's Labcorp position peaked at $3.07M in Q1 2026.
1,059 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Carmel Capital Partners's 13F filing for Q2 2026, filed 30 Jul 2026.